Related Experiment Video
Updated: Jul 2, 2025

09:40
Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
2.6K
Activity of Potassium Channels in CD8+ T Lymphocytes: Diagnostic and Prognostic Biomarker in Ovarian Cancer?
Vivien Jusztus1, Ghofrane Medyouni1, Adrienn Bagosi1
1Department of Biophysics and Cell Biology, Faculty of Medicine, University of Debrecen, Egyetem tér 1., H-4032 Debrecen, Hungary.
International Journal of Molecular Sciences
|February 24, 2024
Summary
Altered expression of Kv1.3 and KCa3.1 ion channels in CD8+ T cells may indicate ovarian cancer. These changes correlate with calcium responses and could serve as diagnostic biomarkers.
Area of Science:
- Immunology
- Oncology
- Cellular Physiology
Background:
- CD8+ T cells are crucial for anti-tumor immunity and immunotherapy effectiveness.
- Ion channels, specifically Kv1.3 and KCa3.1 K+ channels, regulate CD8+ T cell functions like cytokine release and tumor cell lysis by maintaining membrane potential for calcium (Ca2+) influx.
- CRAC channels are essential for Ca2+ signaling in T cells.
Purpose of the Study:
- To investigate the expression and activity of Kv1.3, KCa3.1, and CRAC channels in CD8+ T cells from ovarian cancer patients.
- To determine if these ion channels and Ca2+ responses can serve as potential biomarkers for ovarian cancer diagnostics.
Main Methods:
- Analysis of Kv1.3 and KCa3.1 expression in CD8+ T cells from ovarian cancer patients (n=7) and control/benign tumor groups.
- Assessment of KCa3.1 channel activity.
- Measurement of Ca2+ response in CD8+ T cells.
Main Results:
- Kv1.3 expression was significantly higher in CD8+ T cells from patients with malignant ovarian tumors compared to control or benign groups.
- KCa3.1 channel activity was lower in the malignant tumor group.
- A heightened Ca2+ response via CRAC channels was observed in patients with malignant tumors.
Conclusions:
- Dysregulated expression of Kv1.3 and KCa3.1 in CD8+ T cells from ovarian cancer patients may serve as a diagnostic reporter or biomarker.
- Elevated Ca2+ signaling through CRAC channels might contribute to impaired CD8+ T cell function in ovarian cancer.

